Imagion Biosystems (ASX:IBX) is set to raise AU$3 million via the placement of 150 million shares priced at AU$0.02 apiece, along with 75 million options exercisable at AU$0.04, according to a Thursday filing with the Australian Securities Exchange.
The directors of the medical imaging company subscribed for an aggregate of 6.25 million shares and 3.125 million options, subject to shareholder approval, the filing said.
Proceeds will fund the MagSense platform's clinical programs in cancer diagnosis, and provide general working capital, according to the filing.
CPS Capital Group was the broker and lead manager for the placement.
Imagion Biosystems' shares fell nearly 14% in afternoon trade.
Price (AUD): $0.03, Change: $-0.0050, Percent Change: -13.51%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.